Lundquist David J. 4
4 · NEWLINK GENETICS CORP · Filed Nov 18, 2011
Insider Transaction Report
Form 4
Lundquist David J.
Director
Transactions
- Conversion
Series C Preferred Stock
2011-11-16−20,000→ 0 total(indirect: By Trust)→ Common Stock (20,000 underlying) - Conversion
Common Stock
2011-11-16+13,267→ 24,642 total(indirect: By Trust) - Conversion
Common Stock
2011-11-16+10,856→ 45,021 total(indirect: By Trust) - Conversion
Series AA Preferred Stock
2011-11-16−27,780→ 0 total(indirect: By Trust)→ Common Stock (27,780 underlying) - Purchase
Common Stock
2011-11-16$7.00/sh+15,000$105,000→ 87,630 total(indirect: By Trust) - Conversion
Series B Preferred Stock
2011-11-16−19,999→ 0 total(indirect: By Trust)→ Common Stock (19,999 underlying) - Conversion
Series E Preferred Stock
2011-11-16−5,257→ 0 total(indirect: By Trust)→ Common Stock (5,257 underlying) - Conversion
Common Stock
2011-11-16+9,523→ 34,165 total(indirect: By Trust) - Conversion
Common Stock
2011-11-16+27,609→ 72,630 total(indirect: By Trust) - Gift
Common Stock
2011-11-18−87,630→ 0 total(indirect: By Trust) - Gift
Common Stock
2011-11-18+43,815→ 43,815 total(indirect: By Trust) - Gift
Common Stock
2011-11-18+43,815→ 43,815 total(indirect: By Trust)
Footnotes (5)
- [F1]Every one share of Series AA Preferred Stock automatically converted into approximately 0.476 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date. Includes 39 shares acquired by dividend issued upon conversion of Series AA Preferred Stock.
- [F2]Every one share of Series B Preferred Stock automatically converted into approximately 0.476 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
- [F3]Every one share of Series C Preferred Stock automatically converted into approximately 0.542 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
- [F4]Every one share of Series E Preferred Stock automatically converted into approximately 5.252 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
- [F5]The shares were purchased in the Issuer's initial public offering.